Corcept Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Aurora Cannabis Inc ACB:CN 236.49M 107.07M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 37107M 343M
Canopy Growth Corp WEED:CN C$ 1.26B 270.14M
Corcept Therapeutics CORT:US $ 0M 0M
Depomed DEPO:US $ 49.5M 11.75M
Eleven Biotherapeutics EBIO:US $ 0 0
Eli Lilly And LLY:US $ 14692M 460.9M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Knight Therapeutics Inc GUD:CN C$ 11.86M 2.11M
Lannett LCI:US $ 614.95M 4.87M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 23784M 589M
Novartis NVS:US $ 23784M 589M
Omeros OMER:US $ 314.36M 454K
Pacira Pharmaceuticals PCRX:US $ 721.88M 7.86M
Supernus Pharmaceuticals SUPN:US $ 0M 400.38M
Ziopharm Oncology ZIOP:US $ 4.47M 5.85M